ERBB2 and neoplasm: Our in vivo study also demonstrated that the HER2 Affibody-IR700Dye conjugate and the trastuzumab-Alexa488 conjugate bound to the HER2 protein and imaged only HER2-positive tumor (MDA-MB361) specifically.